News | News By Subject | News by Disease News By Date | Search News

Tumor (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
CEO of Bay Area’s Iovance Biotherapeutics Sees TIL Technology as Best Immunotherapy Option for Treating Solid Tumors     9/7/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics     6/15/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data     4/6/2017
Before We Act Impulsively on Drug Prices We Should Make Precision Policies     4/4/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials     3/14/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017     12/22/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer     10/19/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR     4/25/2016
Kite Pharma (KITE) Cancer Therapy Responses in Solid Tumors Continued in Small Trial, NCI Review Halts Patient Enrollment     4/18/2016
Fluorescence Lighting Up Clinical Research     3/3/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Analyst Questions High Cost of T Cell Therapies as Potential Frontline Treatment for Blood Cancers     2/25/2016
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos     2/11/2016

News from Around the Web
A Pen That Detects Cancerous Tissue Could Help Surgeons Remove The Full Tumor, Science Translational Medicine Reveals     9/7/2017
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
New Device Detects Tumor Cells In Blood, Universitat Rovira i Virgili Study Reveals     7/18/2017
Researchers Develop Tumor-Targeting MRI Contrast Based On Human Protein, University of Massachusetts Medical School Reveals     7/10/2017
Injectable Plant-Based Nanoparticles Delay Tumor Progression, Case Western Reserve University School of Medicine Study     6/29/2017
New MRI Technique Images Glucose In Body To Spot Tumors, German Cancer Research Center (DKFZ) Study Reveals     6/29/2017
Microscope Can Scan Tumors During Surgery And Examine Cancer Biopsies In 3-D, University of Washington Study Reveals     6/28/2017
A Mechanical Trigger For Toxic Tumor Therapy, Harvard Medical School Study     6/16/2017
Scientists Move Closer To Detecting Cancer Long Before Any Symptoms Appear, GRAIL Reveals     6/12/2017
A 'Sci-Fi' Cancer Therapy Fights Brain Tumors, Study Finds     4/3/2017
Toward Glow-In-The-Dark Tumors: New Fluorescent Probe Could Light Up Cancer, Michigan Tech Study Reveals     3/30/2017
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
Miniature Brain And Skull Found Inside 16-Year-Old Girl's Ovary, Shiga Medical Centre Study     1/11/2017
How Strata Oncology Plans To Sequence 100K Tumors For Free     12/22/2016
SurgVision Displays Tumors During Surgery     12/14/2016

Press Releases
AbbVie (ABBV) And Bristol-Myers Squibb (BMY) Announce Clinical Research Collaboration To Evaluate A Therapeutic Regimen In Advanced Solid Tumors     9/22/2017
PharmaMar Starts Clinical Studies With A New Compound –PM14- In Patients With Solid Tumors     9/20/2017
DelMar Pharma Announces Issuance Of New Patent On First-In-Class DNA-Targeting Agent, VAL-083     9/20/2017
Natera Selected For Circulating Tumor DNA Study In Bladder Cancer     9/20/2017
Daiichi Sankyo Presents New Data For DS-8201 In Multiple HER2-Expressing Solid Tumors At European Society For Medical Oncology (ESMO) 2017 Congress     9/11/2017
Lycera Presents Encouraging Safety Results From Phase I ARGON Study Of LYC-55716 At The European Society For Medical Oncology (ESMO) Congress     9/11/2017
Tyme Presentation At ESMO Reported 100% Of Current Prostate Cancer Patients Have Demonstrated A Reduction In Circulating Tumor Cells, Most Becoming Undetectable     9/11/2017
Stemline (STML) Presents SL-801 Phase I Data At ESMO 2017     9/11/2017
BeiGene (BGNE) Presents Preliminary Phase I Data For BGB-A317 In Multiple Solid Tumors At The ESMO 2017 Congress     9/11/2017
Innate Pharma (IPH.PA ) Release: New Preclinical Data Further Strengthen The Rationale Of IPH5401 And Monalizumab     9/11/2017
Merck KGaA (MKGAF.PK), Darmstadt, Germany, ‘Grant For Oncology Innovation’ Awards Recognize Recipients For Pushing Boundaries In Oncology Research     9/11/2017
Foundation Medicine (FMI), Roche (RHHBY) Blood Test Could Help 'Personalize' Cancer Immunotherapy     9/8/2017
BeiGene (BGNE) Presents Preliminary Phase I/II Clinical Data On PARP Inhibitor BGB-290 In Patients With Advanced Solid Tumors At The European Society For Medical Oncology 2017 Congress     9/8/2017
Idera Pharma (IDRA) Presents Pre-Clinical Data From IMO-2125 Treatment In Combination With Ipilimumab That Demonstrates Induction Of Durable Anti-Tumor Responses Associated With Tumor-Specific Memory     9/8/2017
Advanced Accelerator Applications And FUJIFILM RI Pharma Announce First Patient In Bridging Study In Japan For Lutetium Lu 177 Dotatate* (Lutathera)     9/6/2017

//-->